Results 1 to 10 of about 57,235 (275)

Can Antinuclear Antibodies (ANA) be Monoclonal? [PDF]

Case Reports in Nephrology, 2021
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal ...
Laura Biederman, Anjali A. Satoskar, Mohankumar Doraiswamy, Samir Parikh, Brad Rovin, Brian Mussio, Galina Mikhalina, Sergey V. Brodsky   +7 more
doaj   +2 more sources

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

Indian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti, K Venkatesh, D. V S. B Rama Murthy, Swapna Kameti, K Sri Devi, K V Chandrika   +5 more
doaj   +2 more sources

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

PLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy, Daniel Bertin, Nathalie Bardin, Isabelle Auger, Marie-Caroline Guzian, Jean-Pierre Mattei, Sandrine Guis, Jean Roudier, Nathalie Balandraud   +8 more
doaj   +7 more sources

Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students [PDF]

Journal of Primary Care & Community Health
Introduction: Antinuclear antibodies (ANA) are the hallmark of many connective tissue disorders (including lupus), which comprise roughly 5% to 10% of chronic debilitating diseases causing morbidity and mortality.
Karol Laskowski, Justyna Paszkiewicz, Dorota Plewik, Adam Szepeluk, Kamil K. Hozyasz   +4 more
doaj   +2 more sources

Significance of antinuclear antibodies in patients with COVID-19 [PDF]

The Korean Journal of Internal Medicine, 2023
Oh-Hyun Cho
doaj   +2 more sources

Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis

Biomedicines, 2022
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the presence of antimitochondrial and antinuclear antibodies in patients’ serum.
Alicja Bauer, Andrzej Habior, Damian Gawel   +2 more
doaj   +1 more source

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019
In this work we reviewed the key antimitochondrial and antinuclear antibodies in primary biliary cholangitis – an autoimmune cholestatic disorder with destruction of intralobular biliary ductules.
Dana Saipiyeva, Manarbek Askarov, Turlybek Tuganbekov, Kulsara Rustemova, Vladimir Grigorevsky, Gulmira Dossatayeva, Nina Tostanovskaya   +6 more
doaj   +1 more source

Antimelanocyte antibodies: A possible role in patients with vitiligo

Indian Journal of Dermatology, 2020
Background: Vitiligo is an acquired depigmenting skin disorder with multifactorial pathogenesis including genetic, autoimmune, and neuronal factors. Both humoral- and cell-mediated immunities are supposed to have a role in the pathogenesis of vitiligo ...
Maha A El-Gayyar, Manal E Helmy, Eman R Amer, Moustafa A Elsaied, Mohammad A Gaballah   +4 more
doaj   +1 more source

Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System. [PDF]

, 2015
ObjectiveIn 2013, the American College of Rheumatology (ACR) participated in the Choosing Wisely campaign and devised a recommendation to avoid testing antinuclear antibody (ANA) subserologies without a positive ANA and clinical suspicion of disease. The
Davis, Lisa Anne, Goldstein, Barbara, Hirsh, Joel, Keniston, Angela, Storfa, Amy, Tran, Vivian, Yazdany, Jinoos, Zell, JoAnn   +7 more
core   +2 more sources

Do we need broad immunological work-up in all patients with CIS? [PDF]

, 2012
BACKGROUND: The aim of this study was to determine the prevalence of altered immunological tests and their clinical significance in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS). ----- PATIENTS AND METHODS:
Adamec, Ivan, Bošković, Mateja, Gabelić, Tereza, Habek, Mario, Posavec, Vanja, Radmilović, Marin, Škvorc, Ana   +6 more
core   +1 more source